Physician profile
Hesham Mostafa
NPI 1780978866
$2,006.42
in general payments reported to CMS, 2019-2025
25 companies · $568 in 2025
The $568 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $44.27 · 2021: $557 · 2022: $178 · 2023: $224 · 2024: $95.24 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.91 |
| Education | $197.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $492.14 | 2019-2025 | Xtandi, Myrbetriq |
| Histosonics, INC. | $222.23 | 2025 | |
| Janssen Biotech, INC. | $155.81 | 2019-2025 | Erleada |
| Myovant Sciences INC. | $147.43 | 2021-2022 | |
| Boston Scientific Corporation | $142.02 | 2019-2024 | |
| Medtronic, INC. | $130.63 | 2023 | Interstim |
| Coloplast Corp | $124.32 | 2019-2023 | Speedicath |
| Endo Pharmaceuticals INC. | $69.23 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $60.71 | 2021-2025 | |
| Blue Earth Diagnostics | $55.79 | 2019-2024 | |
| Urovant Sciences INC | $50.94 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.05 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $44.72 | 2021 | |
| Sumitomo Pharma America, INC. | $37.81 | 2025 | Orgovyx |
| Allergan, INC. | $36.81 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $31.88 | 2025 | Lynparza |
| Halozyme INC | $27.00 | 2023 | |
| Dendreon Pharmaceuticals LLC | $25.42 | 2019 | |
| Axonics, INC. | $21.64 | 2022 | |
| Antares Pharma, INC. | $18.35 | 2025 | Xyosted |
| Avanos Medical | $17.28 | 2022 | |
| Pfizer INC. | $14.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.50 | 2019 | |
| Cook Medical LLC | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hesham Mostafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.